Pain in patients with ankylosing spondylitis (AS) may stem from factors other than spinal inflammation, researchers said after discovering…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
Many ankylosing spondylitis (AS) patients who start treatment with a TNF-blocker switch treatments, use additional medications, or stop the…
CreakyJoints has released a guide for people living with ankylosing spondylitis, the first to be developed by patients and…
Obese patients with axial spondyloarthritis are less likely to respond to treatment with TNF blockers than patients at a healthy…
Health Canada has approved Sandoz’s Erelzi, a biosimilar therapy of etanercept, for the treatment of ankylosing…